Longevity Market Recap – August 2024

New patents and conferences this month.

Investments in the longevity sector have been heating up, with large-scale backing of research targeting longevity-promoting supplements, technological advancements, and novel treatments for Alzheimer’s.

Tech breakthroughs & new research

Improving hair loss through biotech

Yuva Biosciences has partnered with Elevai Labs to develop new hair loss prevention technology. Recently, the companies filed a joint patent to protect their hair- and scalp-enhancing technology. Yuva’s Y100 mitochondrial technology and Elevai’s exosome-based treatments were combined to address hair loss in the creation of the S-Series Root Renewal System. This latest partnership marks a new stage in longevity solutions that focus on both internal and external signs of aging.

Launch of new digital health platform for longevity

Ciba Health, a digital healthcare company, has just announced the launch of a new platform designed to prevent, manage, and potentially reverse chronic health conditions. Called Thrive, the platform draws from data-driven insights combined with access to over 100 lab tests, data analytics, and continuous support from a multidisciplinary care team, including dieticians and physicians, to offer its users personalized health insights and strategies to improve their longevity by taking control of their personal health.

DAOs and communities

First 3-DAO collaboration funded: Transfidelity

76 ETH, the Ethereum network’s native currency, was raised through the collaboration of BeakerDAO, VitaDAO, and CerebrumDAO. As of August 31, this can be converted to approximately $200,000 USD. The funding, currently in the negotiation stage, is set to support a solution that aims to tackle this issue by improving protein production accuracy, potentially preventing harmful aggregates in neurodegenerative disease. Although current therapies treat symptoms, this new approach seeks to target the root causes.

Other DeSci and longevity news

Institute of Computation (IoC) launched by Altos Labs

Altos Labs has launched its Institute of Computation (IoC), aiming to leverage AI and play a pivotal role in Altos’ mission to restore cellular health. Focusing on harnessing the power of data and computational platforms for cellular rejuvenation research, the IoC complements Altos Labs’ existing Institutes of Science and Medicine. The newest edition is set to be led by Dr. Hana El-Samad and Dr. Thore Graepel, backed by an equally impressive team.

De Novo Foodlabs secures investment for new food supplement

The company formerly known as De Novo Dairy secured an investment to develop a precision-fermented, animal-free version of lactoferrin, a protein with significant health benefits, crafted using machine learning and biopharma discovery models. This latest funding round positions the company as one of the top solutions for supplements with a total investment of $4 million across various funding rounds.

Vandria receives backing from Hevolution Foundation and Dolby Family Ventures

In a Series A funding round, which garnered investments of $30.7 million, Vandria, a biotech focusing on mitochondrial therapeutics has received backing from Hevolution Foundation and Dolby Family Ventures. The latest round will go towards supporting the development of VNA-318, a therapy targeting neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases, supporting clinical trials and future initiatives.

Learn More on Lifespan.io...